Article

Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord.

Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Developmental Brain Research (Impact Factor: 1.78). 07/2003; 143(1):33-46. DOI: 10.1016/S0165-3806(03)00097-X
Source: PubMed

ABSTRACT Aralar1 and citrin are two isoforms of the mitochondrial carrier of aspartate-glutamate (AGC), a calcium regulated carrier, which is important in the malate-aspartate NADH shuttle. The expression and cell distribution of aralar1 and citrin in brain cells has been studied during development in vitro and in vivo. Aralar1 is the only isoform expressed in neurons and its levels undergo a marked increase during in vitro maturation, which is higher than the increase in mitochondrial DNA in the same time window. The enrichment in aralar1 per mitochondria during neuronal maturation is associated with a prominent rise in the function of the malate-aspartate NADH shuttle. Paradoxically, during in vivo development of rat or mouse brain there is very little postnatal increase in total aralar1 levels per mitochondria. This is explained by the fact that astrocytes develop postnatally, have aralar1 levels much lower than neurons, and their increase masks that of aralar1. Aralar1 mRNA and protein are widely expressed throughout neuron-rich areas in adult mouse CNS with clear enrichments in sets of neuronal nuclei in the brainstem and, particularly, in the ventral horn of the spinal cord. These aralar1-rich neurons represent a subset of the cytochrome oxidase-rich neurons in the same areas. The presence of aralar1 could reflect a tonic activity of these neurons, which is met by the combination of high malate-aspartate NADH shuttle and respiratory chain activities.

0 Bookmarks
 · 
205 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glutamate and GABA are the quantitatively major neurotransmitters in the brain mediating excitatory and inhibitory signaling, respectively. These amino acids are metabolically interrelated and at the same time they are tightly coupled to the intermediary metabolism including energy homeostasis. Astrocytes play a pivotal role in the maintenance of the neurotransmitter pools of glutamate and GABA since only these cells express pyruvate carboxylase, the enzyme required for de novo synthesis of the two amino acids. Such de novo synthesis is obligatory to compensate for catabolism of glutamate and GABA related to oxidative metabolism when the amino acids are used as energy substrates. This, in turn, is influenced by the extent to which the cycling of the amino acids between neurons and astrocytes may occur. This cycling is brought about by the glutamate/GABA - glutamine cycle the operation of which involves the enzymes glutamine synthetase (GS) and phosphate-activated glutaminase together with the plasma membrane transporters for glutamate, GABA, and glutamine. The distribution of these proteins between neurons and astrocytes determines the efficacy of the cycle and it is of particular importance that GS is exclusively expressed in astrocytes. It should be kept in mind that the operation of the cycle is associated with movement of ammonia nitrogen between the two cell types and different mechanisms which can mediate this have been proposed. This review is intended to delineate the above mentioned processes and to discuss quantitatively their relative importance in the homeostatic mechanisms responsible for the maintenance of optimal conditions for the respective neurotransmission processes to operate.
    Frontiers in Endocrinology 01/2013; 4:102.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Energy metabolism supports both inhibitory and excitatory neurotransmission processes. This study investigated the specific contribution of astrocytic metabolism to γ-aminobutyric acid (GABA) synthesis and inhibitory GABAergic neurotransmission that remained to be ilucidated in vivo. Therefore we measured (13) C incorporation into brain metabolites by dynamic (13) C nuclear magnetic resonance spectroscopy at 14.1 T in rats under α-chloralose anaesthesia during infusion of [1,6-(13) C]glucose. The enhanced sensitivity at 14.1 T allowed to quantify incorporation of (13) C into the three aliphatic carbons of GABA non-invasively. Metabolic fluxes were determined with a mathematical model of brain metabolism comprising glial, glutamatergic and GABAergic compartments. GABA synthesis rate was 0.11±0.01 μmol/g/min. GABA-glutamine cycle was 0.053±0.003 μmol/g/min and accounted for 22±1% of total neurotransmitter cycling between neurons and glia. Cerebral glucose oxidation was 0.47±0.02 μmol/g/min, of which 35±1% and 7±1% was diverted to the glutamatergic and GABAergic tricarboxylic acid cycles, respectively. The remaining fraction of glucose oxidation was in glia, where 12±1% of the TCA cycle flux was dedicated to oxidation of GABA. 16±2% of glutamine synthesis was provided to GABAergic neurons. We conclude that substantial metabolic activity occurs in GABAergic neurons and that glial metabolism supports both glutamatergic and GABAergic neurons in the living rat brain. This article is protected by copyright. All rights reserved.
    Journal of Neurochemistry 06/2013; · 3.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria play an important role in adaptation of organisms to changing environmental conditions and type of food. Human mitochondrial DNA (mtDNA) has discrete branches with a group of related mtDNA sequences called a haplogroup. D. C. Wallace stressed that people with different haplogroups have different predisposition to various pathological conditions [1]. Mitochondrial dysfunctions are important in pathogenesis of many major pathologies, particularly neurodegenerative diseases. In this review we analyze the current hypotheses regarding energy metabolism of the brain’s two major cell types - neurons and astroglia. Recently, it was clearly shown that up to 20% of the total brain’s energy is provided by mitochondrial oxidation of fatty acids. However, the existing hypotheses consider glucose, or its derivative lactate, as the only main energy substrates for the brain. Astroglia metabolically supports the neurons by providing lactate as a substrate for neuronal mitochondria. In addition, a significant amount of neuromediators, glutamate and GABA, are transported into neurons and also serve as substrates for mitochondria. Thus neuronal mitochondria may simultaneously oxidize several substrates. Astrocytes have important function to replenish the pool of neuromediators by synthesis de novo, which requires large amounts of energy. In this review we made an attempt to reconcile β-oxidation of fatty acids by astrocytic mitochondria with the existing hypothesis on regulation of aerobic glycolysis. As a result, it becomes clear that under condition of neuronal excitation, both metabolic pathways may exist simultaneously. We also provide experimental evidence that isolated neuronal mitochondria may oxidize palmitoyl carnitine in the presence of other mitochondrial substrates. We briefly discuss the possible roles of variations in mitochondrial metabolic phenotypes in predisposition to neurodegenerative diseases among individuals belonging to different mtDNA haplogroups.
    BioMed Research International 01/2014; In press(The Road to Mitochondrial Dysfunctions). · 2.71 Impact Factor

Full-text

View
30 Downloads
Available from
Jun 5, 2014